Investor Relations Captor Therapeutics ®
Quarterly report for I quarter 2025
The documents posted on this website are translated versions of the original reports issued in Polish. These documents have been prepared only for informational purposes. Only the original versions of these reports are binding.
Attachments:
1) Interim Condensed Consolidated and Separate Financial Statements prepared for the three months ended March 31, 2025 (pdf)
2) Extended Consolidated Quarterly Report of the Group for the period 1 January 2023 - 31 March 2023 (pdf)